Boston, MA -- (SBWIRE) -- 10/23/2013 -- Global Market Direct's pharmaceuticals report, "RNL BIO Co., Ltd. - Product Pipeline Review - 2013" provides data on the RNL BIO Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, RNL BIO Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from RNL BIO Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- RNL BIO Co., Ltd. - Brief RNL BIO Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of RNL BIO Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of RNL BIO Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the RNL BIO Co., Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate RNL BIO Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of RNL BIO Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the RNL BIO Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with RNL BIO Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of RNL BIO Co., Ltd. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- RNL BIO Co., Ltd. - Product Pipeline Review - 2012
- Karo Bio AB - Product Pipeline Review - 2013
- Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2013
- Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013
- Psoriatic Arthritis - Pipeline Review, H2 2013
- Alzheimer's Disease - Pipeline Review, H2 2013
- Apricus Biosciences, Inc. - Product Pipeline Review - 2013
- Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2013
- Benign Prostatic Hyperplasia - Pipeline Review, H2 2013
- Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2013